HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2015 - 2025)

HUTCHMED (China)'s (HCM) quarterly Non-Current Deffered Revenue came in at $20.1 million in Q4 2025, down 34.6% on a QoQ basis from $30.8 million in Q2 2025.

HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 10 years of Non-Current Deffered Revenue data on file, last reported at $20.1 million in Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $20.1 million in Q4 2025; TTM through Dec 2025 was $20.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $20.1 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 stood at $20.1 million, down from $30.8 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for HCM reached as high as $97.2 million in Q2 2023 and fell as low as $190000.0 in Q4 2022.
  • Historically, Non-Current Deffered Revenue has averaged $41.8 million across 4 years, with a median of $30.8 million in 2025.
  • Across the five-year window, Non-Current Deffered Revenue plunged 37.61% in 2024 and slumped 49.22% in 2025, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $190000.0 in 2022, then soared by 51045.26% to $97.2 million in 2023, then tumbled by 37.61% to $60.6 million in 2024, then sank by 66.79% to $20.1 million in 2025.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $20.1 million in Q4 2025, $30.8 million in Q2 2025, and $60.6 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - 20.13 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 20.13 Mn
Jun 30, 2025 30.79 Mn
Jun 30, 2024 60.63 Mn
Jun 30, 2023 97.18 Mn
Dec 31, 2022 190,000.00
Dec 31, 2020 484,000.00
Dec 31, 2019 133,000.00
Dec 31, 2018 408,000.00
Dec 31, 2017 1.99 Mn
Dec 31, 2016 131,000.00
Dec 31, 2015 2.13 Mn